Search reports.
High Potency Active Pharmaceutical Ingredients Market [2031]
Get free sample report Request for Customiztion Buy Now

High Potency Active Pharmaceutical Ingredients Market [2031]

Segments - High Potency Active Pharmaceutical Ingredients Market by Products (Biotech and Synthetic), Manufacturers (Outsourced and In-house), Drug Types (Generic and Innovative), Applications (Oncology, Hormonal, Glaucoma, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023-2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2289 | 4.8 Rating | 60 Reviews | 145 Pages | Format : PDF Excel PPT

Report Description


High Potency Active Pharmaceutical Ingredients Market Outlook 2031

The High Potency Active Pharmaceutical Ingredients Market was USD 25.17 Billion in 2022 and is likely to reach USD 43.25 Billion by 2031, expanding at a CAGR of 6.2% during 2023 – 2031. The growth of the market is attributed to the increasing incidence of cancer globally. 

High potency active pharmaceutical ingredients are active substances that unveil biological activity at tremendously low concentrations. These are manufactured either provided to contract manufacturing organizations or in-house by the formulator company. Captive facility or in-house is generally opted by most of the companies in case of any exclusive drugs manufacturing.

The properties possessed by these anti-cancerous drugs such as effectiveness and minimum exposure of drug to the non-cancerous cell are some of the key factors. In addition, high potency active pharmaceutical ingredients are also used as antibody drug conjugates (ADCs). ADCs are the most important & effective treatment in combination with biologically active and monoclonal antibodies drug for the cancer.

 

High Potency Active Pharmaceutical Ingredients Market Outlook

For the treatment of cancer, several drugs are used but some of them are cytotoxic in nature and are dangerous to the non-cancerous cells, which may cause substantial damage to health. At the same time, the use of low efficacious drug is not effective in cancer treatment; hence, the targeted therapy method came into existence.

  • Wide number of cancer patients globally is a major driver expected to accelerate the growth of the market.

  • Rising expansion of the pharmaceutical & biotech industry and increasing investments in R&D activities in developing economies are expected to fuel the market growth.

  • Development of advanced anti-cancerous drugs for cancer treatment, which has less damage to the non-cancerous cell are the factor contributing to the market growth.

  • Advancement of multiple separation technology including purification, fermentation, and filtration processes with advanced technology to provide growth platform to this market in the coming years.

  • Some of pharmaceutical companies have made large investments in developing In-house capabilities and exclusive needs for In-house high potency active pharmaceutical ingredients investments. This is expected to boost the market growth.

  • Side effects of chemotherapy and effects on non-cancerous cells are expected to be a key restraint for the market growth.

Scope of High Potency Active Pharmaceutical Ingredients Market Report

The report on the global high potency active pharmaceutical ingredients market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

High Potency Active Pharmaceutical Ingredients Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Products (Biotech and Synthetic), Manufacturers (Outsourced and In-house), Drug Types (Generic and Innovative), and Applications (Oncology, Hormonal, Glaucoma, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Pfizer Inc.; Sigma Aldrich Corporation; Eli Lilly and Company; Novartis International AG; Lonza Group; Teva Pharmaceutical Industries Ltd.; Roche Diagnostics; Bristol-Myers Squibb; Boehringer Ingelheim AG & Ko.; Covidien Plc.; Merck & Co., Inc.; Sanofi S.A.; BASF SE; Hospira Inc.; and Carbogen Amcis AG.

High Potency Active Pharmaceutical Ingredients Market Segment Insights

Biotech segment is expected to grow at a rapid pace

Based on products, the global high potency active pharmaceutical ingredients market is bifurcated into biotech and synthetic. The biotech segment accounted for a key share of the market in 2019 and is expected to grow at a rapid pace in the coming years owing to technology advancements and high efficacy. However, the synthetic segment is anticipated to expand at a healthy growth rate during the forecast period due to minimum side effects of the products used for the cancer treatment.

High Potency Active Pharmaceutical Ingredients Market Products 

In-house segment is projected to expand at a considerable CAGR

On the basis of manufacturers, the market is segmented into outsourced and in-house. The in-house segment is projected to expand at a considerable CAGR during the forecast period owing to intensive capitalization by key players in the market. Meanwhile, the outsourced segment is anticipated to hold a large market share during the forecast period due to advancement in manufacturing technology.

Generic segment is expected to exhibit a robust growth rate

Based on drug types, the global high potency active pharmaceutical ingredients market is bifurcated into generic and innovative. The generic segment held a key share of the market in 2019 and is expected to exhibit a robust growth rate during the projected period due to the presence of unmet clinical needs and rising demand for the treatment drugs. However, the innovative segment is anticipated to constitute a major market share during the forecast period owing to favorable government initiatives and wide establishment of research and development activities.

High Potency Active Pharmaceutical Ingredients Market Drug Types

Hormonal segment is expected to register a high CAGR

On the basis of applications, the market is segregated into oncology, hormonal, glaucoma, and others. The hormonal segment is expected to register a high CAGR during the projected period due to increased prevalence of metabolic disorders worldwide. On the other hand, the glaucoma segment is anticipated to grow significantly during the forecast period owing to growing obese population especially in developed countries.

North America is anticipated to constitute a key market share

In terms of regions, the global high potency active pharmaceutical ingredients market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America accounted for a key share of the market in 2019 and is anticipated to constitute a key market share in the coming years as the incidences of cancer is higher and wide expansion of the healthcare research projects in this region.

On the other hand, the market of Asia Pacific is expected to represent a large market share during the forecast period owing to growing pharmaceutical sector and increasing healthcare facilities in the region.

High Potency Active Pharmaceutical Ingredients Market Regions

Segments

The global high potency active pharmaceutical ingredients market has been segmented on the basis of

Products

  • Biotech
  • Synthetic

Manufacturers

  • Outsourced
  • In-house

Drug Types

  • Generic
  • Innovative

Applications

  • Oncology
  • Hormonal
  • Glaucoma
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Pfizer Inc.
  • Sigma Aldrich Corporation
  • Eli Lilly and Company
  • Novartis International AG
  • Lonza Group
  • Teva Pharmaceutical Industries Ltd.
  • Roche Diagnostics
  • Bristol-Myers Squibb
  • Boehringer Ingelheim AG & Ko.
  • Covidien Plc.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • BASF SE
  • Hospira Inc.
  • Carbogen Amcis AG.

Competitive Landscape

Key players competing in the global high potency active pharmaceutical ingredients market are Pfizer Inc.; Sigma Aldrich Corporation; Eli Lilly and Company; Novartis International AG; Lonza Group; Teva Pharmaceutical Industries Ltd.; Roche Diagnostics; Bristol-Myers Squibb; Boehringer Ingelheim AG & Ko.; Covidien Plc.; Merck & Co., Inc.; Sanofi S.A.; BASF SE; Hospira Inc.; and Carbogen Amcis AG. The main market players are continuously engaged in various market development activities such as mergers, acquisitions, research and developments, and investments for innovative products and collaborations to expand their market positions.

High Potency Active Pharmaceutical Ingredients Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. High Potency Active Pharmaceutical Ingredients Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. High Potency Active Pharmaceutical Ingredients Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. High Potency Active Pharmaceutical Ingredients Market - Supply Chain
  4.5. Global High Potency Active Pharmaceutical Ingredients Market Forecast
     4.5.1. High Potency Active Pharmaceutical Ingredients Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. High Potency Active Pharmaceutical Ingredients Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. High Potency Active Pharmaceutical Ingredients Market Absolute $ Opportunity
5. Global High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Applications
     5.3.1. Oncology Hormonal Glaucoma Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global High Potency Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
7. North America High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Applications
     7.4.1. Oncology Hormonal Glaucoma Others
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America High Potency Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
8. Latin America High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Applications
     8.4.1. Oncology Hormonal Glaucoma Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America High Potency Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
9. Europe High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Applications
     9.4.1. Oncology Hormonal Glaucoma Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe High Potency Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
10. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Applications
     10.4.1. Oncology Hormonal Glaucoma Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific High Potency Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
11. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa High Potency Active Pharmaceutical Ingredients Market Size and Volume Forecast by Applications
     11.4.1. Oncology Hormonal Glaucoma Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa High Potency Active Pharmaceutical Ingredients Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global High Potency Active Pharmaceutical Ingredients Market: Market Share Analysis
  12.2. High Potency Active Pharmaceutical Ingredients Distributors and Customers
  12.3. High Potency Active Pharmaceutical Ingredients Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Pfizer Inc. Sigma Aldrich Corporation Eli Lilly and Company Novartis International AG Lonza Group Teva Pharmaceutical Industries Ltd.  

Methodology

Our Clients

Honda Motor Co. Ltd.
General Electric
FedEx Logistics
Pfizer
sinopec
General Mills
The John Holland Group
Nestle SA